Status:
NOT_YET_RECRUITING
Mg Wire for Augmentation of ACL Reconstruction
Lead Sponsor:
Chinese University of Hong Kong
Collaborating Sponsors:
Alice Ho Miu Ling Nethersole Hospital
Kwong Wah Hospital
Conditions:
Anterior Cruciate Ligament Rupture
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
Background: ACLR with autologous tendon graft is commonly used for the treatment of ACL injury. However, as the BTI healing is poor, this can lead to a failure rate of 5% in the first-year post-operat...
Eligibility Criteria
Inclusion
- Age 18-40
- Unilateral ACL tear for primary ACLR (Single bundle, Hamstring) confirmed clinically and radiologically.
Exclusion
- Concomitant multiple ligament injuries requiring additional surgical procedures,
- Preoperative radiographic signs of arthritis,
- Revision ACLR
- Femoral tunnel interference screws
- Contralateral knee with ACL deficiency or reconstruction
- Medical co-morbidities
- Long-term steroid intake
- Non-compliance to our rehabilitation protocol.
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05983692
Start Date
June 1 2024
End Date
September 1 2027
Last Update
February 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong
Hong Kong, Hong Kong